The luteinizing hormone preovulatory surge stimulates several signal pathways essential for ovulation, and the regulator of G-protein signaling protein-2 (RGS2) is thought to be involved in this process. The objectives of this study were to characterize the regulation of RGS2 transcripts in equine and bovine follicles prior to ovulation and to determine its transcriptional control in bovine granulosa cells. To assess the regulation of equine RGS2 prior to ovulation, RT-PCR was performed using total RNA extracted from equine follicles collected at various times after human chorionic gonadotropin (hCG) injection. Results showed that RGS2 mRNA levels were very low at 0 h but markedly increased 12-39 h post-hCG (P , 0.05). In the bovine species, results revealed that RGS2 mRNA levels were low in small and dominant follicles and in ovulatory follicles obtained at 0 h, but markedly increased in ovulatory follicles 6-24 h post-hCG (P , 0.05). To study the molecular control of RGS2 expression, primary cultures of bovine granulosa cells were used. Stimulation with forskolin induced an up-regulation of RGS2 mRNA in vitro. Studies using 5 0 -deletion mutants identified a minimal region containing full-length basal and forskolin-inducible RGS2 promoter activities. Site-directed mutagenesis indicated that these activities were dependent on CRE and ETS1 cis-elements. Electrophoretic mobility shift assays confirmed the involvement of these elements and revealed their interactions with CREB1 and ETS1 proteins. Chromatin immunoprecipitation assays confirmed endogenous interactions of these proteins with the RGS2 promoter in granulosa cells. Forskolin-inducible RGS2 promoter activity and mRNA expression were markedly decreased by PKA and ERK1/2 inhibitors, and treatment with an antagonist of PGR (RU486) and inhibitors of PTGS2 (NS398) and EGFR (PD153035) blocked the forskolin-dependent RGS2 transcript expression, suggesting the importance of RGS2 in ovulation. Collectively, this study reports for the first time the gonadotropin-dependent up-regulation of RGS2 in equine and bovine preovulatory follicles and presents some of the regulatory controls involved in RGS2 gene expression in granulosa cells.
INTRODUCTION
One class of cell surface receptors is known to couple to heterotrimeric guanine nucleotide-binding proteins, referred to as G proteins, which consist of a Ga subunit and a Gbc heterodimer [1] . In the absence of extracellular ligand, the Ga subunit is bound to guanosine diphosphate (GDP) and associated with a Gbc heterodimer. Upon ligand binding to the receptor, the G protein is activated, leading to the exchange of GDP for guanosine triphosphate (GTP) and dissociation of the GTP-bound Ga subunit from a Gbc heterodimer [1] . Once released, activated Ga subunit and Gbc heterodimer interact with a number of signaling molecules, including phospholipases Cb, adenylyl cyclase, and mitogen-activated protein kinases (MAPKs), to mediate biological processes such as cell proliferation, cell morphology changes, and gene transcription activation [2, 3] . The G protein signaling activation is terminated by the conversion of GTP to GDP catalyzed by Ga subunit GTPase activity and reassociation of a GDP-bound Ga subunit with a Gbc heterodimer [4] . However, because the intrinsic rate of Ga subunit GTPase-mediated GTP conversion appears slow and insufficient to account for the rapid termination of the intracellular signaling observed in vivo [4] , the involvement of other proteins able to stimulate Ga subunit GTPase activity has been suggested.
Regulators of G-protein signaling (RGS) are a group of proteins involved in the modulation of G protein-coupled receptor (GPCR) signaling that act as GTPase-activating proteins (GAPs) [5, 6] . They contain a highly conserved RGS domain that is sufficient and critical for GAP activity. Binding of this domain to activated Ga subunit markedly increases (up to 2000 times) its GTPase activity, inducing the rapid reassociation of GDP-bound Ga subunit and Gbc heterodimer, thereby reducing the amplitude and duration of Ga-and Gbc-mediated downstream signaling [5, 6] . More than 20 mammalian RGS proteins have been identified, which are divided into four subfamilies (R4/B, RZ/A, R7/C, and R12/D) based on primary sequence homology of the RGS domain and the size and organization of sequences flanking the RGS domain [7] . Many RGS proteins contain additional domains that facilitate functions other than accelerating GTPase activity, including protein-protein interactions, protein stability, and subcellular localization [7] . Numerous studies have shown that some RGS proteins are constitutively expressed at high levels in resting cells and down-regulated by treatment of cAMPelevating agonists in various cell types [8, 9] . In contrast, transcript levels of RGS2, a member of the R4/B subfamily, are typically low in resting cells but are markedly increased over several hours by different stimuli in many cell types [8, [10] [11] [12] [13] . This increase is linked to the regulation of a number of biological activities, including cardiovascular function, im-mune responses, vascular tone and blood pressure, anxiety, bone formation, and cancer [14] .
The binding of luteinizing hormone (LH) to its receptor (LHR) in granulosa cells triggers ovulation, a physiological process during which the activation of numerous signaling pathways leads to the induction of genes required for follicle rupture and the release of a fertilizable oocyte [15] [16] [17] . The LHR belongs to the GPCR family, and RGS2 is thought to be involved in regulating G protein activation during the ovulatory process. However, information about RGS2 regulation in ovarian follicles remains scarce. One report showed the gonadotropin-dependent up-regulation of Rgs2 transcripts prior to ovulation in vivo in the rat ovary [18] , whereas another showed that RGS2 transcripts were induced by human chorionic gonadotropin (hCG) in vitro in human and mouse luteinized granulosa cell lines [19] . In contrast, little is known about RGS2 regulation in ovarian follicles of large monoovulatory animal species, including the horse and the cow. Furthermore, the molecular mechanisms involved in RGS2 upregulation in follicular cells during ovulation remain largely unknown. Therefore, the objectives of the present study were to characterize the gonadotropin-dependent regulation of RGS2 transcripts in equine and bovine preovulatory follicles prior to ovulation, and to determine some of the molecular control of RGS2 transcriptional activation in follicular cells.
MATERIALS AND METHODS

Materials and Reagents
Lipofectamine Plus reagent, TRIzol total RNA isolation reagent, 1-kb DNA ladder, synthetic oligonucleotides, culture medium, and fetal bovine serum were obtained from Invitrogen Life Technologies. [ 32 P]dCTP was purchased from PerkinElmer Life Sciences. The dual-luciferase reporter assay system and plasmids pGEM-T Easy, pGL3-basic, and pRL.SV40 were obtained from Promega Corp. Restriction enzymes were purchased from Amersham Pharmacia Biotech. CREB1, CREB2 and ETS1 polyclonal antibodies and protein A/G-Sepharose beads were obtained from Santa Cruz Biotechnology, Inc. The Expand High-Fidelity PCR system was obtained from Roche Applied Science (Laval, QC, Canada). Proteinase K, the OneStep RT-PCR system, and the DNeasy tissue kit were purchased from Qiagen Inc. Forskolin (FSK) and signaling pathway inhibitors were purchased from Calbiochem. RU486, prostaglandin E2 (PGE2), phorbol 12-myristate 13-acetate (PMA), and soluble recombinant human epidermal growth factor (EGF) were obtained from SigmaAldrich. NS398, butaprost, and AH6809 were purchased from Cayman Chemical. The QuikChange site-directed mutagenesis kit was obtained from Stratagene.
Animal Tissues and RNA Extraction
Equine preovulatory follicles were isolated at specific stages of the estrous cycle from Standardbred and Thoroughbred mares, as previously described [20] . Briefly, when preovulatory follicles reached 35 mm in diameter during estrus, the ovulatory process was induced by injection of hCG (2500 IU, i.v.) and ovariectomies were performed via colpotomy using an ovariotome at 0, 12, 24, 36, and 39 h post-hCG (n ¼ 4-6 mares/time point). The interval of time from hCG administration to ovulation (i.e., the length of the ovulatory process) corresponded to 39-42 h in the group of animals used in the present study [20] . Corpora lutea (n ¼ 3 mares) were isolated on Day 8 after ovulation (Day 0 ¼ day of ovulation). Preovulatory follicles and corpora lutea were dissected from the surrounding ovarian tissues with a scalpel. Follicles were further dissected into three cellular preparations, including a follicular wall preparation (theca interna with attached granulosa cells) and isolated preparations of granulosa cells and theca interna cells, as described [21] .
For bovine preovulatory follicles, Holstein heifers (2-3 yr old) exhibiting normal estrous cycles were used as previously described [22, 23] . Briefly, estrous cycles were synchronized with 25 mg prostaglandin F2a (Lutalyse; Upjohn), and ovarian follicular development was monitored by daily transrectal ultrasonography until ovariectomy. Dominant follicles (8-12 mm in diameter; n ¼ 4 cows) were isolated by ovariectomy (via colpotomy) from heifers on Day 5 of the estrous cycle (Day 0 ¼ day of estrus), whereas small follicles (2-4 mm in diameter; n ¼ 3 pools [20 follicles/pool]) were obtained from slaughterhouse ovaries. For ovulatory follicles, luteolysis was induced on Day 7 of the estrous cycle, and an ovulatory dose of hCG (3000 IU) was administered 36 h after the induction of luteolysis. The ovary bearing the preovulatory follicle was isolated 0-24 h post-hCG (n ¼ 4 cows/time point). The interval of time from hCG administration to ovulation is 26-28 h in this animal model. Follicles were dissected from the ovary with a scalpel, and follicular wall preparation (theca interna with attached granulosa cells) and isolated preparations of granulosa and theca interna cells were obtained as described [22] . Corpora lutea were obtained on Day 5 of the estrous cycle (n ¼ 3 cows).
Total RNAs were extracted from tissues with TRIzol reagent according to manufacturer's instructions using a Kinematica PT 1200C Polytron Homogenizer (Thermo Fisher Scientific). The relative purity of each cellular preparation is estimated to exceed 95% based on the selective expression of P450 17a-hydroxylase-C17-20 lyase (CYP17A1) and P450 aromatase (CYP19A1) mRNAs by theca interna and granulosa cells, respectively [24] . All animal procedures were approved by the Institutional Animal Care and Use Committee of the Université de Montréal and were consistent with the Guidelines of the Canadian Council of Animal Care.
Semiquantitative RT-PCR
The semiquantitative analysis of RGS2, ribosomal protein L7a (RPL7A), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels in follicular cells was performed using total RNA extracts (100 ng), the OneStep RT-PCR kit as directed by the supplier, and specific sense and antisense primers, as previously described [25] . Primers used for amplifying cDNAs were designed from sequences published in GenBank ( 30, 28 , and 25 cycles for RGS2, RPL7A, and GAPDH, respectively. PCR products were resolved on 2% Tris-acetate/EDTAagarose gels containing ethidium bromide (0.5 lg/ml), and the intensity of the band was quantified by densitometry using ImageQuant software (Amersham Pharmacia Biotech). PCR products were subcloned into pGEM-T Easy vector and sequenced to confirm their identity.
Bovine RGS2 Promoter Constructs
A fragment of the bovine RGS2 promoter was obtained by PCR amplification using specific primers (oligonucleotides 1 [sense] and 2 [antisense]; Table 1 ), an extract of bovine genomic DNA, and the Expand Long Template PCR system, as previously described [25] . Oligonucleotides were designed from a bovine RGS2 gene sequence published in GenBank (NC_007314). The genomic DNA extract was obtained from a bovine liver using DNeasy tissue kit, as directed by the supplier. PCR reactions consisted of 948C for 30 sec, 588C for 60 sec, and 728C for 2 min, and PCR products were subcloned into pGEM-T Easy and sequenced. This approach provided a 953-bp fragment of bovine RGS2 genomic DNA, spanning the region of À901 to þ52 (þ1 ¼ the first nucleotide of 5 0 -untranslated region [5 0 -UTR]). Deletion mutants of bovine RGS2 promoter, including À854, À350, À161, and À63 relative to the first nucleotide of 5 0 -UTR, were generated by PCR amplification using specific sense primers (oligonucleotides 3, 4, 5, and 6, respectively; Table 1 ) and one common antisense primer (oligonucleotide 7; Table 1 ). Each PCR fragment was inserted upstream of the firefly luciferase reporter gene in the vector pGL3 basic (promoterless) and sequenced. The resulting constructs were referred to as À854/þ18RGS2.LUC, À350/ þ18RGS2.LUC, À161/þ18RGS2.LUC, and À63/þ18RGS2.LUC. To identify putative consensus cis-acting elements within the bovine RGS2 promoter, the promoter sequence was analyzed by the TFSEARCH program (Transfac DB, Biobase GmbH [http://linux1.softberry.com/berry.phtml]). Site-directed mutants for COUP-TF, NK-jB, CRE, and ETS1 cis-elements were generated by PCR amplification as previously described [25] using the construct À350/ þ18RGS2.LUC as template, primers containing a specific point mutation (Table 1) , and the QuikChange site-directed mutagenesis kit following the manufacturer's protocol. Mutations were confirmed by DNA sequencing.
Cell Cultures, Transient Transfections, and Reporter Activity Assays
Pairs of bovine ovaries bearing a newly formed corpus luteum and a dominant follicle (8-12 mm in diameter) of the first wave of the estrous cycle SAYASITH ET AL.
were obtained from a slaughterhouse, and granulosa cells were isolated from the largest follicle and seeded at a density of 1-2 3 10 5 /well in the 24-well plates, as previously described [25, 26] . Confluent cells were serum starved overnight and incubated in serum-free minimum essential media (MEM) in the presence of agonists and antagonists/inhibitors, including PGE2 (50 lM), the PTGER2 agonist butaprost (10 lM), PMA (10 ng/ml), soluble recombinant human EGF (10 ng/ml), FSK (10 lM), or FSK (10 lM) and the PKA inhibitor H89 (10 lM), the p38MAPK inhibitor SB20358 (10 lM), the ERK1/2 inhibitor U0126 (10 lM), the EGFR inhibitor PD153035 (10 lM), the specific PTGS2 (also known as COX-2) inhibitor NS398 (10 lM), and the PTGER2 antagonist AH6809 (50 lM) or the progesterone receptor (PGR) antagonist RU486 (5 lM). After incubation, cells were harvested and total RNA was extracted. For transfection, confluent cells were transiently cotransfected with various RGS2.LUC constructs (360 fmol/well) and the Simian Virus 40 Renilla luciferase control vector (pRL.SV40) (to normalize promoter activities) using 2 ll of Lipofectamine Plus reagent in 0.3 ml of serum/antibiotic-free MEM, following the manufacturer's instructions. After 3 h of transfection, cells were incubated for 24 h in 0.5 ml of fresh MEM in the absence or presence of FSK, and cell lysates were analyzed as previously described [25, 26] .
Protein Extracts and Electrophoretic Mobility Shift Assays
Bovine granulosa cells were cultured (100-mm dish) in the absence or presence of FSK (10 lM). After 24 h of incubation, cells were harvested, and nuclear extracts were prepared as described [25] [26] [27] . Electrophoretic mobility shift assays (EMSAs) were performed as described [25] [26] [27] [wtETS1]) and 3 lg of nuclear extracts. In competitive and supershift EMSAs, nuclear extracts were pretreated for 30 min with unlabeled DNA competitors (wild-type or mutated oligonucleotides) and CREB1, CREB2, or ETS1 antiserum, respectively, before addition of other reagents. Binding complexes were resolved by 5% acrylamide, 0.53 Tris-borate EDTA gel electrophoresis.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed as previously described [25, 27] using granulosa cells cultured in the absence or presence of FSK. After sonication, one fifth of each chromatin extract supernatant was kept as DNA input (positive control), and the remainder was diluted 1:10 in dilution buffer and incubated overnight at 48C in the presence of normal rabbit serum (NRS; negative control) or anti-CREB1, anti-CREB2, and anti-ETS1 antibodies. After incubation, mixtures were incubated with protein A/G-Sepharose beads for 2 h and subsequently washed as previously described [25, 27] . Beads were heated overnight at 658C in 300 ll of TE buffer in the presence of 1% SDS and treated with proteinase K (400 lg/ml) for 2 h at 508C. DNA samples were purified by phenol extraction and ethanol precipitation. The DNA pellet was dissolved in 50 ll of TE buffer. PCR amplifications were performed with DNA (2 ll) samples and sense (5 0 -GT CGC CTG CGA CCG TTC AAA AGG-3 0 ) and antisense (5 0 -GCT GTC ACG GGC GCC GCA GAA GG-3 0 ) primers specific for the bovine RGS2 promoter. The PCR product (273 bp) containing CRE and ETS1 cis-elements was analyzed by 1% agarose gel electrophoresis.
Statistical Analysis
Levels of RGS2 mRNA were normalized with those of the control gene RPL7A or GAPDH for equine and bovine samples, respectively. Homogeneity of variance between groups was verified by the O'Brien and Brown-Forsythe tests. One-way ANOVA was used to test the effect of time after hCG and FSK treatment on RGS2 mRNA levels and relative luciferase activity (Firefly/ Renilla). When ANOVA indicated significant differences (P , 0.05), the Tukey-Kramer test was used for multiple comparisons of individual means among SF, DF, OF, and CL groups, whereas the Dunnett test (P , 0.05) was used to compare different time points after hCG with 0 h, and for other multiple comparisons of individual means. Data were presented as least-square means 6 SEM. Statistical analyses were performed using JMP software (SAS Institute, Inc., Cary, NC). 
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RESULTS
Regulation of RGS2 mRNA in Equine and Bovine Preovulatory Follicles
To study the regulation of RGS2 transcript in equine follicles during the ovulatory process, RT-PCR analyses were performed using total RNA extracted from the wall (theca interna with attached granulosa cells) of equine preovulatory follicles isolated 0-39 h post-hCG, and corpora lutea obtained on Day 8 of the estrous cycle. Results showed that levels of RGS2 mRNA were low before hCG treatment (0 h), markedly and significantly increased 12-39 h post-hCG, and remained increased, albeit to lower levels, in corpora lutea (Fig. 1A) . To determine the contribution of each cell type in the expression of follicular RGS2 transcript, RT-PCR analyses were performed with isolated preparations of granulosa cells and theca interna obtained from preovulatory follicles collected 0-39 h after hCG. Results revealed that the expression of RGS2 transcript was very low in granulosa (Fig. 1B) and theca interna (Fig. 1C ) cells of follicles obtained at 0 h, but highly and significantly increased thereafter in both follicular cell types.
To determine the expression of RGS2 transcript in bovine follicles, total RNA extracts prepared from granulosa cells obtained from small follicles (2-4 mm in diameter), dominant follicles obtained on Day 5 of the estrous cycle, ovulatory follicles obtained 24 h post-hCG, and corpora lutea on Day 5 of the cycle were analyzed by RT-PCR. Results showed that levels of RGS2 transcript were high in ovulatory follicles (P , 0.001) but varied from low to undetectable in other preparations of follicles or corpora lutea ( Fig. 2A) . As high levels of RGS2 transcript were observed in ovulatory follicles, the gonadotropin-dependent regulation of RGS2 mRNA in bovine follicles prior to ovulation was characterized using total RNA extracted from the wall (theca interna with attached granulosa cells) of follicles collected 0-24 h post-hCG. Results showed that levels of RGS2 transcript were low in follicles obtained at 0 h but markedly increased 6-24 h post-hCG ( Fig.  2B ; P , 0.05). A similar pattern of RGS2 mRNA induction was observed with isolated preparations of granulosa ( Fig. 2C ; P , 0.05) and theca interna (data not shown) obtained from bovine preovulatory follicles collected 0-24 h post-hCG.
Regulation of Bovine RGS2 Transcript and Promoter in Granulosa Cells In Vitro
To study the regulation of RGS2 mRNA in vitro, granulosa cells were isolated from bovine dominant follicles and cultured in the presence of FSK for various times, and total RNA extracts were prepared and analyzed by RT-PCR. Results showed that levels of RGS2 mRNA were very low or undetectable at 0 h, but significantly increased at 12 and 24 h post-FSK ( Fig. 3A ; P , 0.05 vs. 0 h). The pattern of RGS2 mRNA induction was very similar to that observed in vivo following hCG treatment, thus validating the use of this model in vitro for further studying the molecular control of RGS2 gene expression.
To study the regulation of the bovine RGS2 promoter in granulosa cells, a 953-bp fragment of bovine RGS2 genomic DNA spanning the region of À901 to þ52 (þ1 ¼ the first nucleotide of 5 0 -UTR) was isolated, and a series of 5 0 -deletion mutants was generated and inserted upstream of the firefly luciferase reporter gene in the pGL3.basic vector (Fig. 3B ). Constructs were transiently transfected into primary granulosa cells, and cells were cultured in the absence (control) and presence of FSK for 24 h. Results from promoter activity assays indicated that levels of reporter activity for the longest fragment (À854/þ18RGS2.LUC) were low but markedly and significantly increased by FSK ( Fig. 3C ; 5.8 6 0.34 and 42.5 6 3.26, respectively, P , 0.05). Deletion of the region between À854 and À350 (À350/þ18RGS2.LUC) did not affect basal and FSK-stimulated promoter activities compared to the longest fragment (Fig. 3C) . However, both activities were markedly decreased with the deletion between À350 and À161 
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(À161/þ18RGS2.LUC) (P , 0.05; Fig. 3C ). Further deletion eliminated most promoter activities, thus identifying a putative role for the region À350/À63 in the FSK-dependent regulation of the RGS2 promoter in bovine granulosa cells (Fig. 3C) .
To identify potential cis-acting elements present within the À350/þ18RGS2 promoter fragment, a sequence analysis was performed using TFSEARCH (Transfac databases; see Materials and Methods). Results revealed several putative cis-acting . RGS2 levels were normalized with those of GAPDH, and results are presented as ratios of RGS2 to GAPDH (mean 6 SEM). Different letters denote samples that differ significantly (A; P , 0.001). Bars marked with an asterisk are significantly different from 0 h (B and C; P , 0.05).
FIG. 3.
RGS2 mRNA regulation and promoter activity in bovine granulosa cells in vitro. A) Granulosa cells from bovine dominant follicles were cultured in the absence or presence of FSK for 0-24 h, and RNA extracts were analyzed by RT-PCR for RGS2 and GAPDH mRNA content. RGS2 levels were normalized with those of GAPDH, and results are presented as ratios of RGS2 to GAPDH. Bars marked with an asterisk are significantly different from 0 h (P , 0.05, mean 6 SEM of three independent experiments). B) Deletion mutant constructs of the bovine RGS2 promoter. C) Primary granulosa cells were transiently cotransfected with RGS2 promoter constructs (B) and the Simian Virus 40 Renilla luciferase vector (pRL.SV40), and incubated for 24 h in the absence (control) or presence of FSK. Promoter activities were analyzed by promoter assays, and results are presented as normalized relative luciferase activity (Firefly/Renilla; mean 6 SEM of triplicate cultures from three independent experiments). Bars marked with a single asterisk (*) and double asterisk (**) are significantly different from control and FSK-treated cultures transfected with À350/þ18RGS2.LUC (À350/þ18), respectively.
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elements, including COUP-TF, NF-kB, ETS1, CRE, HSF2, Ebox, NF-Y, and SP1 (Fig. 4A) . To investigate the potential role of these cis-acting elements in the regulation of RGS2 promoter activities, site-directed mutants of COUP-TF, NF-kB, ETS1, and CRE were generated in the context of the À350/ þ18RGS2.LUC construct and transfected into granulosa cell cultures. Results showed that the mutation of COUP-TF (DCOUP-TF) and NF-kB (DNF-kB) had no effect on luciferase activities as compared to the wild-type construct (Fig. 4B) . In contrast, mutation of the ETS1 (DETS1) or CRE (DCRE) element significantly reduced basal and FSK-inducible promoter activities, whereas mutation of both elements (DETS1/ DCRE) abolished both activities (Fig. 4B) , thereby pointing to a critical role of ETS1 and CRE elements in RGS2 promoter activation in bovine granulosa cells.
FIG. 4.
Site-directed mutagenesis studies of the RGS2 promoter in bovine granulosa cells. A) Nucleotide sequence of the bovine À350/þ18 RGS2 promoter fragment with potential binding sites and corresponding consensus sequences (bold letters). B) Site-directed mutants were generated within the context of the À350/þ18 RGS2 promoter fragment. Granulosa cells were cotransfected with the SV40 Renilla luciferase vector (pRL.SV40) and the wildtype À350/þ18RGS2.LUC construct (Wild type), or constructs containing point mutations (D) in the putative COUP-TF, NF-kB, ETS1, or CRE elements, or in both ETS1 and CRE elements. After transfection, cells were cultured for 24 h in the absence (control) or presence of FSK. Results from promoter assays are presented as relative luciferase activity (Firefly/Renilla; mean 6 SEM of triplicate cultures from three independent experiments). Bars marked with a single asterisk (*) and double asterisk (**) are significantly different from control and FSK-treated cultures transfected with wild-type À350/þ18RGS2.LUC, respectively.
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Binding Activities to the Bovine RGS2 Promoter
To identify transcription factors interacting with the RGS2 promoter, EMSAs were performed using labeled doublestranded oligonucleotides and nuclear extract proteins isolated from granulosa cells cultured in the absence or presence of FSK. Results revealed that a distinct DNA/protein complex was formed with oligonucleotides derived from the bovine À182/À142 RGS2 promoter fragment containing the CRE element (Table 1 ) as compared to the probe without protein extracts (Fig. 5A, lanes 1 and 2 vs. 3 [arrowhead] ). The intensity of the complex was low with the extract prepared from cells cultured in the absence of FSK (ÀFSK) but appeared increased with the extract from FSK-treated cells (þFSK) (Fig.  5A, lanes 1 and 2, respectively) . To determine the specificity of the DNA/protein complex, competitive EMSAs were performed by the addition of a molar excess of unlabeled DNA competitors to the reactions. Results showed that the complex was completely competed with wtCRE competitor DNA but not with mutated (D) CRE competitor DNA (Fig. 5A, lanes 5 [wtCRE] and 6 [DCRE] vs. 4), thus demonstrating the specificity of the interaction. To identify proteins involved in the DNA/protein complex, supershift EMSAs were undertaken by the addition of antibodies to the reaction. Results revealed that the complex was shifted by the anti-CREB1 antibody but not by the anti-CREB2 antibody, thereby pointing to the presence of CREB1 protein in the DNA-binding complex (Fig.  5A, lanes 7 and 8 vs. 4, respectively) .
Similar studies performed using labeled oligonucleotides derived from the bovine À218/À190 RGS2 promoter fragment containing the ETS1 element (Table 1) showed a formation of a distinct DNA/protein complex when compared to the probe incubated without protein extracts (Fig. 5B, lanes 2 and 3 vs. 1 [arrowhead]). The intensity of the complex was very low with the extract from control cells without FSK (ÀFSK) treatment but increased with the extract from FSK-treated cells (þFSK) (Fig. 5B, lanes 2 and 3, respectively) . Competitive EMSAs indicated that only wtETS1 and not the mutated ETS1 (DETS1) could compete with the labeled complex (Fig. 5B,  lanes 4 and 5 vs. 3, respectively) , and supershift EMSAs showed that the complex was disrupted by the addition of an anti-ETS1 antibody to the reaction (Fig. 5B, lane 6 vs. 3) , thereby confirming the specificity of the ETS1 element and the presence of ETS1 protein in the binding complex.
To determine the presence of endogenous interactions between CREB1 and ETS1 proteins and the bovine RGS2 promoter in vivo, ChIP assays were performed using granulosa cells cultured in the absence (À) or presence (þ) of FSK. Results revealed that binding of CREB1 and ETS1 proteins to the bovine RGS2 promoter was low prior to FSK but markedly increased after FSK stimulation (Fig. 5C) . No binding activity was observed for the CREB2 protein, in keeping with its absence in the binding complex in vitro. Similarly, no binding was generated when NRS was used instead of a specific antibody (negative control; Fig. 5C ).
Effect of Signaling Pathway Inhibitors on RGS2 Promoter Activity and Transcript Expression
To study the involvement of various signaling pathways in the regulation of RGS2 promoter activity, cells transfected with the À350/þ18RGS2.LUC construct were cultured in the presence of agonists or pharmacological inhibitors. The results showed that levels of RGS2 promoter activity were unaffected by PMA (a potent PKC activator) but significantly increased by FSK stimulation (Fig. 6A) . FSK-stimulated RGS2 promoter ]dCTP end-labeled doublestranded oligonucleotides spanning the RGS2 promoter region À182 to À142 containing the wild-type CRE cis-element (wtCRE probe; A), or the RGS2 promoter region À218 to À190 containing the wild-type ETS1 cis-element (wtETS1 probe; B). Protein/DNA interactions were analyzed by EMSAs. In competitive and supershift EMSAs, nuclear extracts from FSK-treated cells were preincubated with molar excess of unlabeled competitor DNA (wtCRE or mutated [D] CRE and ETS1) or the anti-CREB1, anti-CREB2, and anti-ETS1 antibodies prior to the addition of other reagents, respectively. The arrowhead denotes a distinct protein/DNA complex of interest (see Results). The bracket designates a shifted complex induced by the preincubation with the antibody (A and B). C) Granulosa cells were cultured in the absence (ÀFSK) or presence of FSK (þFSK) for 24 h, and endogenous interactions of proteins with the bovine RGS2 promoter were analyzed by ChIP assays. One fifth of chromatin extracts was kept as DNA input (positive control), and the remainder was diluted and incubated with NRS (as negative control) or the anti-CREB1, anti-CREB2, and anti-ETS1 antibodies. A 273-bp DNA fragment containing CRE and ETS1 cis-elements within the bovine RGS2 promoter was amplified by PCR. Depicted bands represent the expected PCR products. None, reactions performed in the absence of protein extracts (probe alone). In all cases, representative results from one of three independent experiments are shown.
RGS2 UP-REGULATION AND PROMOTER ACTIVATION activity was markedly decreased by PKA inhibitor peptide (PKI) overexpression ( Fig. 6A ; P , 0.05). Levels of basal and FSK-stimulated promoter activities were significantly decreased by pharmacological inhibitors of PKA (H89) and ERK1/2 (U0126; U01) but not by an inhibitor of p38MAPK (SB20358; SB), as compared to control cells in the absence of inhibitors (None) (Fig. 6B) . To verify whether these inhibitors affect RGS2 transcript expression, total RNA extracts from granulosa cells cultured for 24 h in the absence and presence of FSK and inhibitors were analyzed by RT-PCR. Results showed that levels of FSK-stimulated RGS2 mRNA were significantly reduced by PKI overexpression or costimulation with H89 or U0126 (U01), but not affected by SB20358 (SB) (Fig. 6C ), in keeping with results from promoter activity assays. Taken together, these results point to the involvement of PKA and ERK1/2 signaling pathways in the up-regulation of RGS2 gene expression in bovine granulosa cells.
PGR activation and prostaglandin G/H synthase 2 (PTGS2) induction in ovarian follicles by the LH/hCG preovulatory surge play a key role in the expression of genes required for ovulation [28] [29] [30] [31] [32] [33] [34] [35] . Previous studies have shown a marked increase in levels of PGR and PTGS2 transcripts in bovine granulosa cell cultured with FSK [26, 27, 36, 37] . In this study, cotreatment with the PGR antagonist RU486 or specific PTGS2 inhibitor NS398 markedly reduced levels of FSKstimulated RGS2 transcripts in bovine granulosa cells ( Fig. 7A ; P , 0.05). Likewise, treatment with PGE2 (a PTGS2-derived product) or selective PGE2 receptor (PTGER2) agonist butaprost significantly increased levels of RGS2 mRNA, whereas treatment with the PTGER2 antagonist AH6809 markedly decreased levels of FSK-stimulated RGS2 transcripts in bovine granulosa cells ( Fig. 7B ; P , 0.05), thereby supporting the putative role of prostaglandins in the regulation of RGS2 expression in granulosa cells.
The EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are induced by LH/hCG stimulation in ovulatory follicles and, through binding to their cognate receptor, are known to regulate the expression of ovulation-related genes [38, 39] . To examine whether EGFR activation was involved in the regulation of RGS2 mRNA expression, granulosa cells were treated with EGF alone or FSK and the EGFR inhibitor PD153035 (PD). Results revealed that levels of RGS2 transcripts were significantly increased by incubation with soluble recombinant human EGF (an AREG/EREG analog) (EGF vs control; Fig. 7C ), whereas FSK-stimulated levels of RGS2 mRNA were markedly reduced by PD153035 (FSK/PD vs. FSK; Fig. 7C ). In all cases, levels of bovine GAPDH mRNA (control gene) remained relatively unchanged.
DISCUSSION
The activation of LHR, a member of the GPCR family, by the LH preovulatory surge stimulates a number of signaling pathways, leading to the induction of genes required for follicle rupture and oocyte release [15] [16] [17] . This activation is known to occur through the exchange of GDP for GTP on the Ga subunit, and to terminate following Ga subunit-catalyzed GTP hydrolysis and reassociation of a GDP-bound Ga subunit with a Gbc heterodimer [1] . RGS proteins interact with the Ga . Results are presented as normalized relative luciferase activity (Firefly/Renilla; mean 6 SEM of triplicate cultures from three independent experiments). Bars marked with a single asterisk (*) and double asterisk (**) are significantly different from control and FSK-treated cultures in the absence of inhibitors (None), respectively. C) Granulosa cells were cultured for 24 h in the absence (Ctl) or presence of FSK or FSK and signaling pathway inhibitors. Changes of RGS2 and GAPDH mRNA levels were analyzed by RT-PCR. RGS2 levels were normalized with those of GAPDH, and results are presented as ratios of RGS2 to GAPDH. Bars marked with brackets are significantly different from treated with FSK alone (P , 0.05, mean 6 SEM of three independent experiments).
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subunit to accelerate its GTPase activity, allowing rapid deactivation of signaling pathways initiated by activated G proteins. RGS2 is constitutively expressed in several tissues [8, [10] [11] [12] [13] , but not the ovary. Indeed, results from the present study revealed a marked hCG-dependent induction of RGS2 transcripts in theca interna and granulosa cells of equine and bovine preovulatory follicles prior to follicular rupture. Interestingly, a similar pattern of RGS2 transcript induction was also observed in primary cultures of bovine granulosa cells in vitro following treatment with FSK (this study), an agonist known to replicate in vitro the gonadotropin-dependent induction of ovulation-related genes observed in vivo [25-27, 29, 37] . These results agree with those previously reported in the rat ovary in vivo [18] and in human and mouse luteinized granulosa cell lines in vitro [19] . However, attempts to demonstrate the regulation of RGS2 protein in granulosa cells by immunoblotting were unsuccessful (this study), as the specificity of a commercially available anti-human RGS2 polyclonal antibody could not be demonstrated (i.e., presence of multiple bands; data not shown). Most importantly, the current work unravels for the first time some of the molecular mechanisms involved in the regulation of RGS2 in granulosa cells of ovarian follicles.
The gonadotropin-dependent increase of RGS2 transcripts in equine follicles occurred relatively early (12 h post-hCG; this study) during the ovulatory process (defined as the interval of time from hCG administration to follicular rupture), which is known to last 39-42 h in this model. RGS2 transcript induction was also shown to occur early (6 h post-hCG; this study) in bovine preovulatory follicles (ovulation occurs 26-28 h posthCG in this mono-ovulatory species) and in rodent follicles (4 h post-hCG; the ovulatory process lasts 12-14 h in this species) [18] . Interestingly, once induced, levels of RGS2 mRNA remained high in both granulosa cells and theca interna of equine and bovine follicles throughout the ovulatory process (the present study). In contrast, the induction of Rgs2 mRNA in rodent follicles appeared transient in nature and cell type specific, with elevated levels of Rgs2 observed only in granulosa cells and between 4 and 8 h post-hCG [18] . Thus, although the early induction of RGS2 transcripts in follicles during the ovulatory process is a mechanism conserved across species, its sustained expression and cellular localization in follicles suggest the presence of species-specific controls [11, 40] .
The binding of transcription factors to DNA motifs within the promoter proximal region is an important mechanism for the regulation of gene expression [41] . Results from the present study revealed that a À350-bp promoter region located immediately upstream of the bovine RGS2 5 0 -UTR was sufficient to confer full-length promoter activity in bovine granulosa cells. Mutation of CRE or ETS1 element within this promoter fragment markedly decreased basal and FSKinducible promoter activities, whereas mutation of both elements completely abolished both activities, thus identifying them as putative key cis-acting elements. Their importance for RGS2 promoter activation in bovine granulosa cells was further evidenced by EMSAs, as shown by the formation of a protein/ DNA complex when a labeled CRE-or ETS1-containing DNA probe was incubated with granulosa cell nuclear extracts. Competitive and supershift EMSAs confirmed the specificity of interactions between CREB1 protein and the CRE and between ETS1 protein and the ETS1 element. Ultimately, ChIP assays confirmed the presence of endogenous interactions between CREB and ETS1 proteins and the RGS2 promoter in bovine granulosa cells. Interestingly, the intensity of protein/ DNA interactions, as detected by EMSAs and ChIP assays, RGS2 UP-REGULATION AND PROMOTER ACTIVATION was increased by FSK, which agrees with the FSK-dependent induction of RGS2 promoter activities and of RGS2 transcripts observed in this study. These results complement those of previous reports that have unraveled some of the regulation of the RGS2 promoter in nonovarian cells. Indeed, the activation of the rodent Rgs2 promoter has been shown to be dependent on CREB protein binding to a CRE element in response to FSK stimulation in vascular smooth muscle cells [42] , on Sp1 protein binding to Sp1 site after methylxanthine/dexamethasone/insulin treatment in differentiating 3T3-L1 preadipocytes [43] , and on Runx2 protein binding to Runx motif following parathyroid hormone treatment in osteoblastic cells [44] . Likewise, binding of a heat shock transcription factor 1 to a conserved heat shock element was required for human RGS2 promoter activation in cervix adenocarcinoma cells after the exposure to febrile temperatures or proteotoxic stress [45] . Collectively, these results clearly suggest that the involvement of specific trans-activating factors and cis-acting elements in RGS2 promoter activation varies according to the cell type and agonist involved.
The preovulatory surge of LH/hCG is known to stimulate adenylyl cyclase, to elevate intracellular cAMP concentration, and to activate PKA, as well as other signaling pathways, in granulosa cells [15] [16] [17] . Findings from the present study showed the ability of FSK (a potent PKA activator) to mimic in vitro the gonadotropin-dependent up-regulation of RGS2 observed after hCG treatment in vivo, thus supporting a potential role of the adenylyl cyclase/cAMP/PKA pathway in the regulation of RGS2 gene in granulosa cells. Such a role was further supported by the inhibitory effect of the PKA inhibitors H89 and PKI on FSK-dependent RGS2 promoter activities and transcript expression (this study). The adenylyl cyclase/cAMP/ PKA pathway has been involved previously in the upregulation of RGS2 mRNA by FSK, angiotensin II, and parathyroid hormone in osteoblastic and vascular smooth muscle cells [42, 46, 47] . However, other agonists and signaling pathways have been shown to stimulate RGS2 expression in various cell types, including phorbol ester PMA in cardiomyocytes [48] , oxytocin in myometrial cells [49] , and hypoxia in myeloid suppressor cells and astrocytes [50, 51] . Previous studies in rodents have shown that the LH/ hCG-dependent activation of ERK1/2 signaling is required for ovulation, as Erk1/2 gene disruption severely impaired LH/ hCG-induced expression of ovulation-related genes in granulosa and cumulus cells [52] . Of interest, the ability of the ERK1/2 inhibitor (U0126) to suppress FSK-dependent RGS2 promoter activity and transcript induction in bovine granulosa cells (this study) also argues for the importance of ERK1/2 signaling in the regulation of RGS2 in preovulatory follicles of large animal species. EGFR activation is another signaling pathway that is essential for the LH-dependent induction of genes required for ovulation [38, 39] . A previous report has revealed that the expression of AREG and EREG is increased by hCG in bovine preovulatory follicles and by FSK in vitro in bovine granulosa cells [53] . In the current study, the ability of the EGFR inhibitor PD153035 to reduce, and of soluble EGF (an analog of AREG/EREG) to stimulate, RGS2 mRNA expression in granulosa cells underscores the potential role of EGFR activation in the regulation of RGS2 in bovine granulosa cells.
Although the gonadotropin-dependent induction of RGS2 appears conserved in all species tested thus far, its precise function in the mechanism of ovulation remains unknown. Previous studies have revealed the up-regulation of PGR in preovulatory follicles after the LH surge [54, 55] , which is known to be involved in the expression of a number of genes essential for ovulation [28, 30, 31] . A potential link between PGR activation and RGS2 expression has been proposed in pregnant rats, in which a sustained PGR activation by progesterone was shown to increase myometrial Rgs2 transcript expression and to prolong pregnancy, whereas PGR inactivation by the progesterone antagonist onapristone decreased myometrial Rgs2 mRNA expression and caused preterm delivery [56] . This link has been recently shown in primary granulosa cells of mice, in which overexpression of PGR-A isoform significantly increased levels of Rgs2 transcripts [57] . Interestingly, the time course of PGR mRNA induction in bovine preovulatory follicles in vivo (3.5, 6 , and 24 h post-GnRH) [54] and in bovine granulosa cells in vitro (Sayasith et al., unpublished results) appear almost similar to that of RGS2 transcripts, suggesting a potential role for PGR in follicular RGS2 expression prior to ovulation. Such a role was supported by the ability of the PGR antagonist RU486 to repress the FSK-dependent induction of RGS2 transcript levels in bovine granulosa cells (this study).
PTGS2 and PGE2 receptor (PTGER2) are required for cumulus expansion and ovulation [32, 33, 58] . PTGS2 expression is induced in preovulatory follicles after the LH surge and in bovine granulosa cells in vitro following FSK stimulation [22, 37] . This induction is known to be involved in the expression of a number of ovulatory genes [32] [33] [34] [35] . Of interest, indomethacin (an antiovulatory agent that inhibits prostaglandin synthesis and PTGS2) has been shown to reduce ovarian expression of Rgs2 mRNA in hCG-stimulated rats [18] , showing a link between prostaglandin synthesis and RGS2 in ovulation. Such a link was supported by the ability of a specific PTGS2 inhibitor NS398 and the PTGER2 antagonist AH6809 to suppress the FSK-dependent induction of RGS2 transcripts, and PGE2 and the PTGER2 agonist butaprost to stimulate the RGS2 transcript expression, in bovine granulosa cells, thus supporting the role of the PTGS2/PGE2/PTGER2 signaling pathway in the increase of RGS2 transcripts. Interestingly, RGS2 has been shown to be highly expressed at an early stage of preadipocyte differentiation [59] and thought to play a key role in cell differentiation [60] . Therefore, a marked gonadotropin-dependent up-regulation of RGS2 in granulosa and theca cells of follicles prior to ovulation (the present study) suggests a potential role of RGS2 in the process of luteinization. Likewise, the involvement of RGS2 in the signaling transduction of granulosa lutein cells, theca lutein cells, and endothelial cells in the corpus luteum may play an important role for the production and release of hormones, because RGS2 is expressed in the corpus luteum (this study and another [61] ). However, further investigations will be required to unravel its precise nature in the ovary.
In summary, this study documents for the first time the gonadotropin-dependent up-regulation of RGS2 in equine and bovine preovulatory follicles prior to ovulation. The temporal gonadotropin-dependent induction of bovine RGS2 transcripts in vivo was replicated in vitro by FSK in primary cultures of bovine granulosa cells. Most importantly, the present study is the first to report some of the molecular controls of follicular RGS2 gene expression in ovarian cells. Activation of the bovine RGS2 promoter by FSK in bovine granulosa cells appears dependent on trans-activating CREB1 and ETS1 proteins, which interact with consensus CRE and ETS1 cisacting elements, respectively. Up-regulation of bovine RGS2 promoter activity and transcript expression in granulosa cells involved multiple signaling pathways, including PKA, ERK1/ 2, and EGFR. Interestingly, the current study provides evidence for PGR activation and PTGS2 induction in the up-SAYASITH ET AL. regulation of RGS2 expression in bovine granulosa cells, suggesting a potential role of RGS2 in the ovulatory process.
